SOURCES SOUGHT
66 -- Assay Kit for Abeta42
- Notice Date
- 8/25/2017
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
- ZIP Code
- 20892-9559
- Solicitation Number
- HHS-NIH-NIDA-SSSA-SS-17-612
- Archive Date
- 9/14/2017
- Point of Contact
- Danielle R. Brown, Phone: 301 480 2385
- E-Mail Address
-
danielle.brown2@nih.gov
(danielle.brown2@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Federal Business Opportunities (FBO) SOURCES SOUGHT NOTICE 1.Solicitation Number: HHS-NIH-NIDA-SSSA-SS-17-612 2.Title: Assay Kit for Abeta42 3.NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing 4.Size Standard: 1,000 Employees 5.Description: This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Background: The concentration of Abeta42 in blood exosomes is low, so we need the most sensitive technique possible. We seek to show differences between patients with Alzheimer's disease and controls. Ultimately, we are developing this methodology as a diagnostic biomarker for Alzheimer's disease. Purpose and Objectives: The purpose of this acquisition is to procure an assay kit to measure concentrations of Abeta42 in peripheral blood exosomes in a large cohort from the Baltimore Longitudinal Study of Aging (BLSA) of the National Institute on Aging (NIA). Project requirements: This is the most sensitive assay for detecting Abeta42 in blood and the only type of kits/discs that are compatible with the Simoa HD-1 Analyzer that is already available at the NIA. Salient characteristics: •AB42 Simoa 2.0 Assay Kit •Disc Kit for Simoa 2.0 •System Buffer 1 •(2 Pack) •System Buffer Combo Pack (1&2) Quantity: •Twenty-Six (26) assay kits •Seven (7) disc kits •Two (2) System Buffer packs •One (1) System Buffer Combo Delivery Date: Within one (1) week after receipt of order (ARO). Other Considerations: Expiration not earlier than 12/31/2017 Capability statement /information sought. Please provide a capability statement, this includes: •Provide evidence the respondent has performed services. •Provide evidence of similar previous contracts of research of the same magnitude. •Information regarding (a) staff expertise, including their availability, experience, and formal and other training; (b) current in-house capability and capacity to perform the work; (c) prior completed project of similar nature; (d) corporate experience and management capability; and (e) examples of prior completed Government contracts, references, and other related information. Please provide your DUNS number, organization name, address point of contact, and size and type of business (e.g., 8(a), HubZone, etc.,) pursuant to the applicable NAICS code and any other information that may be helpful. One (1) copy of the response is required and must be in Microsoft Word or Adobe PDF format using 11-point or 12-point font, 8-1/2" x 11" paper size, with 1" top, bottom, left and right margins, and with single or double spacing. The information submitted must be must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. The response is limited to one to two (1-2) page limit. The 1-2 page(s) do not include the cover page, executive summary, or references, if requested. All responses to this notice must be submitted electronically to the Contract Specialist and Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Danielle R. Brown, Contract Specialist, at Danielle.brown2@nih.gov. The response must be received on or before Wednesday, August 30, 2017 at 12:00PM, Eastern Standard Time. "Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)." PURCHASE DESCRIPTION 1.Statement of Need and Purpose: The purpose of this acquisition is to procure an assay kit to measure concentrations of Abeta42 in peripheral blood exosomes in a large cohort from the Baltimore Longitudinal Study of Aging (BLSA) of the National Institute on Aging (NIA). 2.Background Information and Objective: The concentration of Abeta42 in blood exosomes is low, so we need the most sensitive technique possible. We seek to show differences between patients with Alzheimer's disease and controls. Ultimately, we are developing this methodology as a diagnostic biomarker for Alzheimer's disease. 3.Generic Name of Product: Assay Kit for Abeta42. 4.Purchase Description: This is the most sensitive assay for detecting Abeta42 in blood and the only type of kits/discs that are compatible with the Simoa HD-1 Analyzer that is already available at the NIA. 5.Salient characteristics: •AB42 Simoa 2.0 Assay Kit •Disc Kit for Simoa 2.0 •System Buffer 1 •(2 Pack) •System Buffer Combo Pack (1&2) 6.Quantity: •Twenty-Six (26) assay kits •Seven (7) disc kits •Two (2) System Buffer packs •One (1) System Buffer Combo 7.Delivery Date: Within one (1) week after receipt of order (ARO). Other Considerations: Expiration not earlier than 12/31/2017
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-SSSA-SS-17-612/listing.html)
- Place of Performance
- Address: 251 Bayview Blvd, Baltimore, Maryland, 21224, United States
- Zip Code: 21224
- Zip Code: 21224
- Record
- SN04648566-W 20170827/170825232511-725d1c37fffdc56b745cd342be8b48c8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |